|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development expenses, net | |||||
| General and administrative expenses | |||||
| Impairment of fixed assets | |||||
| Operating income (loss) | |||||
| Other income (expense): | |||||
| Impairment of loans receivable | |||||
| Income on Debt Extinguishment and Conversion | |||||
| Finance income, net | |||||
| Net income (loss) | |||||
| Comprehensive income (loss) | |||||
| Income (loss) per share: | |||||
| Net income (loss) per ordinary share - basic (in Dollars per share) | |||||
| Net income (loss) per ordinary share - diluted (in Dollars per share) | |||||
| Weighted average number of ordinary shares outstanding - basic (in Shares) | |||||
| Weighted average number of ordinary shares outstanding - diluted (in Shares) | |||||
Loading...